ADAG
Adagene Inc.
NASDAQ · Healthcare · Biotechnology · CN
$3.58
−2.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.83x
- Price / sales
- 31.90x
- Price / cash flow
- -5.62x
Enterprise value
- Enterprise value
- $195.2M
- EV / sales
- 20.72x
- EV / EBITDA
- -3.25x
- EV / EBIT
- -3.01x
- Market cap
- $300.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026